Additionally, they observed that treatment with citalopram and fluvoxamine regulates YAP expression, suggesting that inhibiting serotonin receptors and transporters reduces intracellular serotonin levels, thereby modulating YAP expression in CRC [55]. Here, YAP1 is linked to colorectal carcinoma.